Catalent Pharma Solutions, LLC

Catalent is a global Contract Development and Manufacturing Organization (CDMO) serving pharmaceutical, biotech, consumer health, and self-care companies. Founded in 2007 and headquartered in Tampa, Florida, the company operates over 50 sites worldwide with approximately 8,500 employees. Catalent specializes in end-to-end drug development, manufacturing, and supply chain services, leveraging advanced technologies including softgel encapsulation, Zydis Ultra oral fast-dissolve systems, and proprietary molecular optimization platforms. Core service areas include oral dose forms, biologics development and manufacturing (drug substance and drug product), cell and gene therapy, specialty dose delivery (inhalation, nasal, pulmonary systems), clinical supply chain management, and self-care product development. The company provides comprehensive analytical chemistry, formulation development, bioavailability studies, regulatory support, clinical packaging, comparator sourcing, and distribution logistics. Catalent has a proven track record supporting FDA approvals and commercial product launches across multiple therapeutic areas.